Background The National Institute for Health and Clinical Excellence (NICE) has judged Implanon® to be the most cost effective of the long-acting reversible contraception (LARC) methods, and its cost effectiveness is enhanced with increased duration of use. Gwent Sexual and Reproductive Health service provides unrestricted use of Implanon, and with the number of implants fitted increasing annually the service wanted to know how long clients were keeping their contraceptive implants in and the cost of implant provision.
Methods The actual cost of providing Implanon was calculated in a cohort of 493 patients within a community-based sexual and reproductive health service, and compared to that predicted in the NICE Clinical Guideline 30 on LARC.
Results The annual cost for the method (using Implanon) was £77.49, 25% lower than the estimate made by NICE, despite a shorter duration of use of the method.
Conclusion The actual cost in this community-based sexual and reproductive health service may not be transferable to other settings such as general practice.
- cost analysis
- long-acting reversible contraception
- Accepted August 26, 2008.
- Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.